Given that melanoma cells commonly dedifferentiate in response to inflammation [6], and that IFNγ is both vital for effective anti-tumor immune responses and known to induce expression of immunosuppressive proteins in cancer cells [27, 36], it is important to characterize how dedifferentiation modulates the IFNγ response of melanoma. This evidence concerns the gene IFNG and melanoma.